Viewing Study NCT01068795

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:28 PM
Ignite Modification Date: 2026-01-26 @ 4:52 AM
Study NCT ID: NCT01068795
Status: COMPLETED
Last Update Posted: 2016-02-23
First Post: 2010-01-20
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome
Sponsor: HaEmek Medical Center, Israel
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fetal Demise View
None Fetal Growth Restriction View
None Preeclampsia View
None Abruptio Placentae View
None Thromboembolism View
Keywords:

Keywords

Keyword Brief Keyword Text View
None placental syndrome View
None maternal thromboembolic event View
None enoxaparin View
None anti-factor Xa View